These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 22951239

  • 1. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM.
    J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
    [Abstract] [Full Text] [Related]

  • 2. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA.
    J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME.
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI, Fischer HD, Herrmann N, Huo CY, Anderson GM, Rochon PA.
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [Abstract] [Full Text] [Related]

  • 8. MAOIs and depression treatment guidelines.
    Thase ME.
    J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
    [Abstract] [Full Text] [Related]

  • 9. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM, de Leon J.
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ.
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [Abstract] [Full Text] [Related]

  • 13. Selegiline transdermal system: current awareness and promise.
    Pae CU, Lim HK, Han C, Neena A, Lee C, Patkar AA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1153-63. PubMed ID: 17614182
    [Abstract] [Full Text] [Related]

  • 14. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ, Aarons SF, Frances AJ, Brown RD.
    J Clin Psychiatry; 1984 Jul 15; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [Abstract] [Full Text] [Related]

  • 15. Patient compliance with MAO inhibitor therapy.
    Walker JI, Davidson J, Zung WW.
    J Clin Psychiatry; 1984 Jul 15; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [Abstract] [Full Text] [Related]

  • 16. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI, Herrmann N, Walker SE.
    CNS Drugs; 2013 Oct 15; 27(10):789-97. PubMed ID: 23934742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.